Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from TSHA

Why Is Taysha Gene Therapies Stock Falling Friday?

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) stock is trading lower on Friday, with a session volume of 4.695 million, as per data from Benzinga Pro.

Benzinga

How Scholars Lost the Culture War over Texas History

And how they could still start winning it.

Texas Observer

Amid New McCarthyism, the Alliance for Texas History Embraces Diverse Scholarship

“It’s particularly important at a moment when our state leaders have demonstrated that they don't want students to have a really full, inclusive accounting of our state or national past.”

Texas Observer

From analysis to the latest developments in health,
read the most diverse news in one place.

Junction 2 Festival's Sunday brings sunshine, beats and immaculate vibes

Barry Can't Swim, TSHA, Eliza Rose and more see out a stellar edition of one of the UK's most unique EDM festivals

Louder

This month's best new workout music to boost your motivation, according to a fitness editor

These new tracks from Charli xcx, METTE, Bring Me The Horizon and more will keep you moving, stay motivated and get the most from your workouts.

Tom’s Guide

Standing Up for All Texans’ Stories

The new Alliance for Texas History calls for working everyone’s stories “into the fabric of Texas history.”

Texas Observer

A battle over who gets to tell Texas history is brewing into a war over the state historical association’s future

Texas State Historical Association members can’t agree on the makeup of the group’s board. And Executive Director J.P. Bryan, a descendant of Stephen F. Austin, is suing.

The Texas Tribune

Read news from The Economist, FT, and more,
with one subscription

It’s Time to Defend the History of All Texans

The way we learn about our collective past is under attack thanks to new leadership at the Texas State Historical Association (TSHA).

Texas Observer

On my radar: Romy’s cultural highlights

The xx singer-songwriter and guitarist on the film that reminds her of holidays with her dad, reliving the Lionesses’ big win and her housework listening

The Guardian - UK

Those Who Don’t Know the Past…

The outcome of a fight to control a nonprofit group could shape the teaching of history in Texas.

Texas Observer

The London DJs bringing the bangers to Ibiza this summer, from Jamie Jones to Eliza Rose

Our comprehensive guide to the DJs soundtracking party island this summer, and their essential summer tunes

Evening Standard

From M3gan to Doctor Who Worlds of Wonder: a complete guide to this week’s entertainment

Fancy a neat little shocker about a very annoyed android, or an exhibition dedicated to the Doctor? Whatever you’re in the mood for, our critics have you covered for the next seven days

The Guardian - UK

Why Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarket

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose 43% to $2.16 in pre-market trading. Astellas Pharma Inc. announced plans to invest a total of $50 million to acquire 15% of Taysha Gene Therapies.

Benzinga

One to watch: Tsha

With her thoughtful, propulsive dance music, Teisha Matthews has moved to the floor-filling big time

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

What 6 Analyst Ratings Have To Say About Taysha Gene Therapies

Analysts have provided the following ratings for Taysha Gene Therapies (NASDAQ:TSHA) within the last quarter:

Benzinga

Taysha Gene Therapies Lays Off 35% Of staff, Narrows R&D Focus

Taysha Gene Therapies Inc (NASDAQ: TSHA) is the latest company to slim down by

Benzinga

Recap: Taysha Gene Therapies Q4 Earnings

Taysha Gene Therapies (NASDAQ:TSHA) reported its Q4 earnings results on Thursday, March 31, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Taysha Gene Therapies's Earnings Outlook

Taysha Gene Therapies (NASDAQ:TSHA) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Taysha Gene Therapies will report an earnings per share (EPS) of $-1.25.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Taysha Gene Therapies Earnings Conference Call Is Coming Up, Here's What You Need To Know

Taysha Gene Therapies (NASDAQ:TSHA) will host a conference call at 08:00 AM ET on March 31, 2022, to discuss Q4 2021 earnings results.

Benzinga

Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial

Taysha Gene Therapies Inc (NASDAQ: TSHA) reported

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

The University of Texas

Texas Christian University

17 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.